Brief update on various pharmacotherapeutic strategies to lower CV risk
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Ulrich Laufs, MD, PhD
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
John Kastelein, MD, PhD